Home
SCIO Path to Approval
Early Clinical Research
Strategy and TPP
Translational Medicine and Epigenetics
Biologics, Cell and Gene Therapy
Real World Evidence
Repurposing
Orphan Drug Solutions
Biomarkers and Surrogate Endpoints
Regulatory Affairs FDA and EMA
Medical Affairs and Clinical Research
Due Diligence
Trial Management & Trial Rescue
People
Senior Advisors
Candida Fratazzi
Claudio Carini
Federico Goodsaid
Our Team
Our Clients
Our Collaborators
Testimonials
Resources
BBCR Voice
Case Studies
Published Studies
Conferences & Presentations
Job Opportunities
Contact Info
Select Page
`
Tagged: Clinical Trials. Boston biotech
The Strategic Clinical Innovation Organization method, developed by BBCR, can help streamline the clinical trial process by operating on the fundamental principle that strategy and design are keys for the success of drug and medical device development.
March 29th, 2022 | Clinical Trials. Boston biotech
Understanding Personalized Medicine
June 26th, 2019 | Clinical Trials. Boston biotech
Patient-Centricity: Empower and inform patients making them partners in the research process
June 5th, 2019 | Clinical Trials. Boston biotech
Follow Us
Search for:
Categories
Biomarkers & Surrogate Endpoints
Company News
Drug Development
Due Diligence
Early Clinical Development
Industry News
Medical Affairs and Clinical Research
Miscellaneous
Orphan Diseases
Pre-IND
Precision Medicine
Rare Disease
Real World Evidence
Regulatory
Regulatory Affairs
Strategy and TPP
Translation Medicine and Epigenetics
Trial Management
Trial Rescue
Recent Posts
Dr. Candida Fratazzi is a pioneering figure in the area of rare diseases and orphan drug early-stage clinical research and regulatory strategies. With an impressive 20-year track record in this specialized field, Dr. Fratazzi’s contributions have been significant.
BBCR is dedicated to supporting pharmaceutical innovators in the specialized rare diseases and orphan drug indications by developing and nurturing the product’s unique strengths. Our operational mission is to craft customized strategies that achieve cost-effective trials. Reach out today to learn more.
BBCR provides Orphan Drug solutions that empower sponsors with medical insight, ODA application experience, strategic clinical planning, and streamlined trial design.
By collaborating with Boston Biotech Clinical Research, you’ll be working with a team of experts who are dedicated to streamlining the clinical trial process.
BBCR’s mission is to deliver cost-effective clinical plans and regulatory strategies for cell and gene therapy programs in the areas of rare disease. We invite you to learn more at bbcrconsulting.com.
Pin It on Pinterest